Drugs / Neo-BCV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05747339 | Jun 2023 → Dec 2024 | — | Wuxi People's Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neo-BCV | “This is a study of the clinical efficacy and mechanism study of tumor treatment vaccine (TTV, also known as Neo-BCV) in patients with recurrent and refractory advanced solid tumors.” NCT05747339 ↗ |
| Known as | TTV | “This is a study of the clinical efficacy and mechanism study of tumor treatment vaccine (TTV, also known as Neo-BCV) in patients with recurrent and refractory advanced solid tumors.” NCT05747339 ↗ |
| Modality | Vaccine | “tumor treatment vaccine (TTV, also known as Neo-BCV)” NCT05747339 ↗ |
| Route | Subcutaneous | “would be given deep subcutaneously in the arm or near the tumor” NCT05747339 ↗ |